Literature DB >> 20613894

Evolving strategies for ovarian cancer: gynecologic oncology in ASCO's 46th annual meeting.

Tae-Joong Kim1.   

Abstract

Entities:  

Year:  2010        PMID: 20613894      PMCID: PMC2895719          DOI: 10.3802/jgo.2010.21.2.72

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  1 in total

1.  Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.

Authors:  Beth Y Karlan; Amit M Oza; Gary E Richardson; Diane M Provencher; Vincent L Hansen; Martin Buck; Setsuko K Chambers; Prafull Ghatage; Charles H Pippitt; John V Brown; Allan Covens; Raj V Nagarkar; Margaret Davy; Charles A Leath; Hoa Nguyen; Daniel E Stepan; David M Weinreich; Marjan Tassoudji; Yu-Nien Sun; Ignace B Vergote
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.